Estrogen receptors (ERα versus ERβ): friends or foes in human biology? (Q38159771)

30 August 2017

Estrogen receptors (ERα versus ERβ): friends or foes in human biology? (English)

1 reference

30 August 2017

1 reference

Sonia Lobo Planey

1

1 reference

PubMed ID

24188405

30 August 2017

Raj Kumar

series ordinal

2

1 reference

PubMed ID

24188405

30 August 2017

John A Arnott

series ordinal

3

1 reference

30 August 2017

4 November 2013

1 reference

Journal of Receptors and Signal Transduction

30 August 2017

1 reference

30 August 2017

34

1 reference

30 August 2017

1-5

1 reference

30 August 2017

1

1 reference

Estrogen receptors: how do they control reproductive and nonreproductive functions?

30 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Estrogen receptors: therapies targeted to receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Transcription activation by estrogen and progesterone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

The structure of the nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Coregulator function: a key to understanding tissue specificity of selective receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

SUMO and estrogen receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Regulation of estrogen receptor beta activity and implications in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

ER beta: identification and characterization of a novel human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Steroid hormone receptors: many actors in search of a plot

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Gene regulation by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

The human estrogen receptor has two independent nonacidic transcriptional activation functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Identification of Regions within the F Domain of the Human Estrogen Receptor α that Are Important for Modulating Transactivation and Protein-Protein Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

The F-domain of estrogen receptor-alpha inhibits ligand induced receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Solution structure of the DNA-binding domain of the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Molecular basis of agonism and antagonism in the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Delineation of a unique protein-protein interaction site on the surface of the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

ERbeta ligands. Part 1: the discovery of ERbeta selective ligands which embrace the 4-hydroxy-biphenyl template

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

The N-terminal regions of estrogen receptor alpha and beta are unstructured in vitro and show different TBP binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Selective oestrogen receptor modulators: potential therapeutic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Therapeutic potential of selective estrogen receptor modulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Generation and reproductive phenotypes of mice lacking estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

The estrogen receptor family.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Mice, estrogen, and postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Expression of estrogen receptor beta in rat bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Expression of estrogen receptor-alpha in cells of the osteoclastic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Expression and localization of estrogen receptor-beta in murine and human bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Small molecule inhibitors as probes for estrogen and androgen receptor action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Fulvestrant (Faslodex) -- how to make a good drug better

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Nuclear receptor coregulators: modulators of pathology and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Development of subtype-selective oestrogen receptor-based therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

Endocrine therapy of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.853188

10.3109/10799893.2013.853188

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24188405